Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Alibaba Shares Fall as AI Spending Hits Profit 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Add as a preferred source on Google
REDWOOD CITY, Calif., May 04, 2018 -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its financial results for the first quarter 2018 after the close of trading on Monday, May 14, 2018. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may do so by dialing (877) 407-8293 for domestic callers or (201) 689-8349 for international callers. To listen to a live webcast, please visit this link: https://78449.themediaframe.com/dataconf/productusers/avgr/mediaframe/24599/indexl.html
A replay of the call will be available beginning May 14, 2018 at approximately 7:30pm PT/10:30pm ET through May 28, 2018. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13679774. The webcast will also be available on Avinger's website for six months following the completion of the call at: www.avinger.com.
About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.
Public Relations Contact:
Phil Preuss
VP of Marketing & Business Operations
Avinger, Inc.
(650) 241-7900
[email protected]
Investor Contact:
Matt Ferguson
Chief Business Officer & CFO
Avinger, Inc.
(650) 241-7916
[email protected]
